Back to Search Start Over

Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.

Authors :
Christensen B
Sparrow MP
Source :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2017 Jan; Vol. 45 (1), pp. 178-179.
Publication Year :
2017

Subjects

Subjects :
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Crohn Disease
Humans
Immunologic Factors
Treatment Outcome
Adalimumab
Infliximab

Details

Language :
English
ISSN :
1365-2036
Volume :
45
Issue :
1
Database :
MEDLINE
Journal :
Alimentary pharmacology & therapeutics
Publication Type :
Editorial & Opinion
Accession number :
27910149
Full Text :
https://doi.org/10.1111/apt.13842
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details